Back to search

Article

Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals novel antagonist interaction

2023-02-27

Abstract excerpt

<title>Abstract</title><p>The G<sub>s</sub>-protein-coupled adenosine A<sub>2A</sub>receptor (A<sub>2A</sub>AR) represents an emerging drug target for cancer immunotherapy. The clinical candidate Etrumadenant was developed as an A<sub>2A</sub>AR antagonist with ancillary blockade of the A<sub>2B</sub>AR subtype. It constitutes a novel chemotype featuring a poly-substituted 2-amino-4-phenyl-6-triazolylpyrimidine co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2d13f11-629b-5dcf-84cf-d3df96f4ef09
DOI
10.21203/rs.3.rs-2602909/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals novel antagonist interactionDOI 10.21203/rs.3.rs-2602909/v1
Select a neighboring publication to make it the new centre.